We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Opportunity to license Dstl technology: preventing significant leg injuries from mines and improvised explosive devices.
This document contains a synopsis of causation occurring in amputation of the lower limb.
This document contains a synopsis of causation occurring in fractures of the lower limb.
This document contains a synopsis of causation occurring in soft tissue injury of the lower limb.
Following a review, the MHRA has updated previous guidance (DSI/2022/003) on the use of paclitaxel coated devices (PCD) in the treatment of peripheral arterial disease (PAD).
You must tell DVLA if you've had a limb amputated
The national diabetes foot care report presents data for England on lower-limb amputations and hospital admissions for diabetes-related foot disease.
Study protocol for a randomized controlled trial in Regional Anesthesia Techniques for a Planned Randomized Controlled Trial in a Disaster Setting
List of Field Safety Notices from 18 to 22 March 2024.
As part of Dstl's commitment to improving access to technologies, we're making some of our intellectual property (IP) available for free.
Update of diabetes foot care profile indicators with data between 1 April 2018 and 31 March 2021 for commissioning organisations.
Canagliflozin may increase the risk of lower-limb amputation (mainly toes) in patients with type 2 diabetes. Evidence does not show an increased risk for dapagliflozin and empagliflozin, but the risk may be a class effect. Preventive foot care is important...
Annual update of indicators in the diabetes foot care profiles.
Tell DVLA if you have a broken limb and will be unable to drive for more than 3 months
You must tell DVLA if you have a limb disability - download the correct form to let them know
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.